Table 3.

Comparation between sarcopenic and non-sarcopenic patient's characteristics.

Parameter	Overall	Sarcopenia	Normal weight	p-value
Age	61.65 ± 9.49	61.33 ± 9.34	62.09 ± 9.78	0.57
Gender (male)	127 (63.2%)	76 (59.8%)	51 (40.2%)	0.37
MELD score	16.56 ± 7.59	18.69 ± 7.74	13.72 ± 6.39	<0.0001
Child Pugh score	8.79 ± 2.24	9.71 ± 1.90	4.56 ± 2.07	<0.0001
SMI	44.44 ± 6.76	42.38 ± 6.21	47.33 ± 6.53	<0.0001
HGS	22.10 ± 8.55	17.84 ± 5.48	28.04 ± 8.47	<0.0001
Albumin	2.53 ± 0.72	2.27 ± 0.61	2.89 ± 0.71	<0.0001
Sodium	136.3 ± 5.38	134.95 ± 6.00	138.17 ± 3.74	<0.0001
INR	1.47 ± 0.38	1.54 ± 0.41	1.38 ± 0.31	0.002
Thrombocytes	124 (22-552)	129.6 (22-156)	148 (47-552)	0.35
Hepatic Encephalopathy	61 (30.3%)	50 (81.9%)	11 (18.9%)	<0.001
Ascites	157 (78.1%)	109 (69.4%)	48 (30.6%)	<0.0001
Esophageal varices	157 (78.1%)	97 (61.7%)	60 (38.3%)	0.01
Hepato-renal syndrome	7 (3.4%)	7 (100%)	0	0.04
Upper GI bleeding	76 (37.8%)	49 (64.4%)	27 (35.6%)	0.10
Hepatocellular carcinoma	65 (32.3%)	54 (83.0%)	11 (17.0%)	<0.0001
Urinary tract infection	61 (30.1%)	46 (75.4%)	15 (24.6%)	0.0005
Spontaneous peritonitis	40 (19.9%)	35 (87.5%)	5 (12.5%)	<0.0001
Pulmonary infections	34 (16.9%)	24 (70.5%)	10 (29.5%)	0.07
Hospitalization days	10.19 ± 6.03	13.36 ± 5.39	5.98 ± 3.90	<0.0001
30 days readmission	75 (37.5%)	64 (85.3%)	11 (14.7%)	<0.0001
6 months mortality	62 (30.8%)	56 (90.3%)	6 (9.7%)	<0.0001
1 year mortality	122 (60.6%)	96 (78.6%)	26 (21.4%)	<0.0001